Month: June 2019
Rx Deflation in an Era of Rising Costs – Insights from the Generics Industry
Welcome to the second post based on the Axios program Beyond 2020: Making Care Affordable. Featuring leading administration, legislative, and industry stakeholders, the goal was to inspire thought on how best to manage the costs of prescription therapies. The first article in this series delved into the topic of the cost of new gene therapies
Details
THE HIGH COST OF “ONE AND DONE” THERAPIES…OR IS IT REALLY?
Scott Gottlieb, MD being interviewed by Axios’ Bob Herman. A jam-packed hour contemplating the future of health care, just another morning in DC. The Snowfish team heard leading administration, legislative, and industry stakeholders opine on the topic of Beyond 2020: Making Care Affordable, hosted by Axios. On the docket were Scott Gottlieb, MD Former FDA
Details